This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
This federal contract award, valued at $224,562.96, was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services' National Institutes of Health (NIH). The contract was awarded to Infotech Soft, Inc., a for-profit, woman-owned business, and is a Definitive Contract with a Firm Fixed Price. The work is to be performed in Miami, Florida and the contract has a completion date of July 31, 2018. This appears to be a Small...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kitware Inc., a small business S corporation located in Clifton Park, New York. The contract has a ceiling value of $299,999 and is a definitive, firm-fixed-price contract with a completion date of September 5, 2025. The contract is not set aside for a specific business type. The contract involves research and development work,...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Insilicom LLC, a woman-owned, minority-owned small business. The contract is for SBIR (Small Business Innovation Research) Topic 136 - INSILICOM, which involves developing advanced artificial intelligence and knowledge graph technologies for biomedical research and applications. The contract has no set-aside designation and is focused on creating...
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
<p>This federal contract award with ID HHSN272201200386P was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the small business contractor IG Assets Inc. The $99,750.00 firm fixed-price purchase order contract was awarded on April 10, 2012 with a completion date of April 28, 2013. The contract is designated as a total small business set-aside.</p>
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $300,000 firm fixed price definitive contract to Nference Inc., a for-profit organization located in Cambridge, Massachusetts, to deliver on SBIR Topic 111 with a completion date of September 15, 2023. No set-aside designation was used for this award. The contract will support the National Institute of Allergy and Infectious Diseases' mission to conduct and...
This is a $299,986 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Big Eye Diagnostics Inc., a small business manufacturer, for the development and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is part of NIAID's Small Business Innovation Research (SBIR) program, which provides funding to small businesses for innovative research and development. The objective is to create rapid,...